Manitou Investment Management Ltd. cut its holdings in shares of CME Group Inc (NASDAQ:CME) by 3.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 52,224 shares of the financial services provider’s stock after selling 1,788 shares during the period. CME Group comprises approximately 2.7% of Manitou Investment Management Ltd.’s portfolio, making the stock its 17th largest position. Manitou Investment Management Ltd.’s holdings in CME Group were worth $11,037,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of the stock. Venturi Wealth Management LLC bought a new stake in shares of CME Group in the 3rd quarter valued at $36,000. Bartlett & Co. LLC increased its stake in CME Group by 2,471.4% during the 3rd quarter. Bartlett & Co. LLC now owns 180 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 173 shares in the last quarter. Advantage Investment Management LLC increased its stake in CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 100 shares in the last quarter. Independence Bank of Kentucky bought a new stake in CME Group during the 3rd quarter valued at $40,000. Finally, Westside Investment Management Inc. bought a new stake in CME Group during the 2nd quarter valued at $38,000. Institutional investors and hedge funds own 84.80% of the company’s stock.
CME has been the subject of a number of recent research reports. Deutsche Bank boosted their price target on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research note on Friday, August 9th. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, October 18th. Wells Fargo & Co boosted their price target on shares of CME Group from $200.00 to $205.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. UBS Group decreased their price target on shares of CME Group from $220.00 to $218.00 and set a “neutral” rating for the company in a research note on Thursday, October 31st. Finally, Berenberg Bank downgraded CME Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $236.00 to $227.00 in a report on Thursday, September 19th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $203.36.
In related news, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $217.62, for a total transaction of $544,050.00. Following the sale, the chief financial officer now directly owns 30,354 shares of the company’s stock, valued at $6,605,637.48. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Sean Tully sold 7,200 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $223.13, for a total value of $1,606,536.00. Following the sale, the insider now directly owns 19,923 shares in the company, valued at $4,445,418.99. The disclosure for this sale can be found here. Insiders sold 13,636 shares of company stock worth $3,001,008 over the last three months. Corporate insiders own 1.20% of the company’s stock.
NASDAQ CME traded down $0.83 during trading hours on Friday, reaching $198.17. The company’s stock had a trading volume of 1,172,200 shares, compared to its average volume of 1,518,595. The firm’s 50-day moving average price is $208.43 and its 200-day moving average price is $201.58. CME Group Inc has a 1 year low of $161.05 and a 1 year high of $224.91. The company has a market capitalization of $70.53 billion, a price-to-earnings ratio of 29.06, a PEG ratio of 3.86 and a beta of 0.18. The company has a quick ratio of 1.05, a current ratio of 1.04 and a debt-to-equity ratio of 0.14.
CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.15. CME Group had a return on equity of 9.54% and a net margin of 40.93%. The company had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same period in the prior year, the company posted $1.45 EPS. The firm’s quarterly revenue was up 41.3% compared to the same quarter last year. Equities research analysts anticipate that CME Group Inc will post 6.91 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Tuesday, December 10th will be issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.51%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is presently 43.99%.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
See Also: What is the Dividend Aristocrat Index?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.